TinyGemsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced safety and efficacy results from its phase 2 clinical trial. The purpose of the trial, called “755-201-EB,” was to evaluate the safety of INM-755 CBN cream, which consists of the control cream plus the active pharmaceutical ingredient CBN, and obtain preliminary evidence of efficacy in treating symptoms and healing wounds over a 28-day period in patients with epidermolysis bullosa (“EB”). According to the announcement, of the 18 participants assessed, chronic itch improved by a clinically meaningful amount in 12 patients (66.7%). “This is an important day for the company, as we report that INM-755 CBN cream demonstrated sufficient clinically important anti-itch activity to warrant further development. We are very encouraged that INM-755 CBN cream could someday provide itch relief for patients with EB and possibly other diseases,” said Alexandra Mancini, SVP of Clinical and Regulatory Affairs at InMed. “We are deeply grateful for all of the individuals with EB and their families who participated in the study and for the investigators and clinical team who conducted this trial.”

To view the full press release, visit https://ibn.fm/jaq8D

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com and www.BayMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork.

Alex Pearon

Share
Published by
Alex Pearon
Breaks Categories: News

Recent Posts

TinyGemsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Secures Roles in Two U.S. Army Microgrid Projects Valued at $144.6 Million

AZIO AI Holdings (NASDAQ: AZIO), a developer of power infrastructure for artificial intelligence ("AI") campuses,…

2 days ago

TinyGemsBreaks – ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA) Surpasses C$20 Million in Contracted Revenue Backlog Across Global Operations

ZenaTech (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA) announced that its consolidated contracted revenue backlog has…

3 days ago

TinyGemsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Signs Agreement to Support $144.6 Million in U.S. Army Microgrid Contracts

AZIO AI Holdings (NASDAQ: AZIO) announced it has signed a general contracting agreement with Energy…

3 days ago

TinyGemsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Establishes Space and Government Power Team to Pursue Lunar and Defense Infrastructure Opportunities

AZIO AI Holdings (NASDAQ: AZIO) announced the formation of a dedicated space and government power…

4 days ago

TinyGemsBreaks – ZenaTech, Inc. (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA) Secures Energy Sector Survey Contracts With Potential Follow-On Work Totaling Nearly C$1 Million

ZenaTech (NASDAQ: ZENA)  (FSE: 49Q) (BMV: ZENA) announced that its Drone as a Service ("DaaS")…

5 days ago